Short answer
Claritev Corp (CTEV) filed its Q3 2025 10-Q quarterly report on Nov 7, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $246M (up 6.7% year over year) with net income of −$70M.
Q3 2025 key financials · XBRL
- Revenue
- $246M
- +6.7% YoY · +1.8% QoQ
- Net income
- −$70M
- +82.2% YoY · −11.4% QoQ
- Operating margin
- 4.1%
- EPS (diluted)
- −$4.23
- +95.4% YoY · −11.0% QoQ
Source: XBRL data from the Claritev Corp (CTEV) Q3 2025 10-Q on SEC EDGAR. USD.
Claritev Corp Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability, margin, cash-flow, or capital-deployment figures provided in excerpt
- Forward-looking statements subject to risks, uncertainties, and potential significant variance from actual results
Risk Factors
- New SAP ERP implementation risk, triggered by system integration and process-upgrade efforts
- ERP control deficiencies, potentially impairing timely and accurate financial reporting
- Healthcare litigation exposure, including provider and member claims challenging cost-management practices
- International expansion risk, including Foreign Corrupt Practices Act enforcement and anti-corruption penalties
- Global expansion increases exposure to foreign-currency fluctuations and cross-border operating costs
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Claritev Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.